Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Posts Earnings Results, Misses Expectations By $0 08 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Stock analysts at HC Wainwright raised their Q3 2023 earnings estimates for shares of Actinium Pharmaceuticals in a research note issued to investors on Tuesday, August 15th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn ($0.39) per share for the quarter, up […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 1,680,000 shares, a growth of 37.7% from the May 31st total of 1,220,000 shares. Based on an average trading volume of 256,200 shares, the […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Rating) – Equities researchers at Cantor Fitzgerald dropped their FY2023 earnings estimates for Actinium Pharmaceuticals in a research note issued on Wednesday, May 17th. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will post earnings per share of ($1.71) for the year, down from their prior […]
StockNews.com initiated coverage on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Rating) in a report released on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ATNM has been the topic of a number of other research reports. William Blair lowered Actinium Pharmaceuticals from an outperform rating to a market perform […]